Market Access Manager UK

In Licensing: In the dynamic pharmaceutical landscape, In Licensing plays a pivotal role in expanding our product portfolio and enhancing our offerings. By partnering with innovative companies and acquiring rights to promising products, we drive growth and bring advanced treatments to patients. Our strategic approach to selecting and licensing products ensures that we maintain a robust pipeline of therapies that cater to diverse medical. needs.

Out Licensing: Our commitment to advancing healthcare goes beyond our own portfolio. Through Out Licensing, we collaborate with like-minded partners to share our expertise and products for the benefit of global patient populations. By licensing our technologies and products, we contribute to the broader medical community and foster innovation across the industry

Our co-development teams are composed of multidisciplinary experts who combine their knowledge and skills to drive breakthrough solutions. By joining forces with researchers, clinicians, and industry partners, we create an environment where diverse perspectives converge to solve complex medical challenges. These cross-functional teams ensure that our projects are nurtured from concept to realization, resulting in impactful advancements that improve the lives of patients around the world.

In a rapidly evolving landscape, the successful transfer of technology is crucial. Our commitment to excellence extends to our collaboration with Contract Manufacturing Organizations (CMOs). We ensure the seamless transition of our formulations and manufacturing protocols through meticulous technology transfer processes. This collaboration enhances our production capabilities, agility, and quality standards, ultimately benefiting patients who rely on our high-quality pharmaceuticals.

Our logistics management ensures that our pharmaceutical products reach every corner of the globe with utmost efficiency and reliability. By leveraging advanced supply chain technologies, rigorous quality checks, and strategic partnerships, we guarantee timely and secure deliveries. This enables healthcare providers and patients to access our life-changing medications when they need them the most.

Re-purposing: Re-purposing involves taking an existing drug or compound and exploring new therapeutic applications beyond its original intended use.

Re-engineering: Re-engineering in the pharmaceutical industry refers to the process of enhancing the efficiency, quality, and cost-effectiveness of various stages in drug development, manufacturing, or distribution.

Re-formulation: Re-formulation entails modifying the composition of a drug to optimize its therapeutic effects, improve patient adherence, or reduce side effects.

Market Access Manager

UK

Full time

Permanent

Overview

Novumgen – the group of Entrepreneurs and Scientists.

Novumgen is a diverse, integrated specialty pharmaceutical and biological company focused on investing, developing, manufacturing, and supplying innovative products that provide benefits to patients and prescribers. We are focused on delivering life-changing medicines that contribute safety and value to patients, healthcare institutions, and prescribers across the globe. As a company, Novumgen has made a lasting commitment to patient safety, introducing new products to our portfolio while maintaining unrivalled quality and exceptional service to the pharmaceutical industry.

We are currently looking to recruit a Market Access Manager. The role of the Market Access Manager is rudimentary and requires excellent knowledge and communication skills to ensure a smooth operation.

The Company is on a growth trajectory, and we are looking for candidates who align with our purpose, have an entrepreneurial mindset, and want to make an impact on pharmaceutical research. You will join a friendly, dynamic, and committed international team to deliver consistent results to tight deadlines.

Job Summary

We are looking for a candidate with an in-depth understanding of the external NHS, healthcare environment, and commissioner-provider interface, to work with the franchise teams in the development of brand-related Market Access strategy. You will manage the implementation of health economics, market access, and reimbursement strategies for prioritized products in local markets and healthcare systems. An assertive and flexible individual, the Market Access Manager will be responsible for commercial activities for launching our medication in the UK and is expected to manage all phases of the process, from hands-on activities such as research information to dossier submission and support during pricing negotiations. They will also provide strategic support for market launches in non-European countries.

We would like to meet motivated individuals, who are excellent team players but also able to work independently.

Impeccable professional standing and the ability to build and keep internal and external relationships are essential to the role.

Candidate Duties

• Promote products to local authorities, access key decision makers, in the NHS, and Healthcare professions.
• Chase, and follow up with key decision-makers, highlighting active product availability.
• Research & identify market access opportunities map out pathways, market access trends/health policy changes, and continuously map reimbursement requirements. Anticipate access barriers, and develop relevant strategies, ensuring meeting all client expectations.
• Writing and delivering client presentations.
• Prepare national pricing & reimbursement files and support listing negotiations.
• Identify and engage possible consultants, source quotes, and recommend consultants to management.
• Prepare market access briefs for sales team.
• Work in close coordination with the Development and Commercial department to support new business development.
• Manage relationships with KOLs, Patient and Professional Associations relevant to the role.
• Co-ordinating and participating in advisory boards to provide the country perspective.
• Ensures legal excellence and compliance in all market access efforts as per local laws and regulations.

Candidate Requirements

• Work Experience: at least 5+ years local experience in Market Access in the healthcare industry.
• Proven track record of successful submissions to NICE.
• Technical Knowledge: Strong understanding of the current and future access and policy environment for drugs. Good knowledge of the drug development process (Local HTA process – pricing, reimbursement; Economic Modelling, Payer research, Payer advocacy etc) and global commercialization environment with proven track record of implementing successful Market Access strategies. Proven track record of successful collaboration across multiple functions (e.g.: regulatory, medical or commercial function) throughout the product lifecycle.
• Extensive experience in product launches with planning and execution through local payer assessments.
• Proven track record of leading effective price and access negotiation strategies.
• Development of key value generation tools and objection handling.
• Experience in articulation requirements for RWE, HEOR to develop HE models.
• Strong business acumen with excellent communication skills and stakeholder management.
• Developing or making recommendations for Price Policy or Access Strategy for pipeline or inline products and effectively communicating the impact of those decisions to the commercial business.
• Ability to present a well-reasoned business case and influence other departmental leaders to support cross-functional implementation of new initiatives and projects.
• High performer, strong team commitment with the ability to manage uncertainty.
• Ability to work independently and to solve complex problems and multiple projects in a supervisory city.
• Strong team player with abilities to work in a multicultural environment.
• Proven ability to present a well-reasoned business case and influence other departmental leaders to support cross-functional implementation of new initiatives and projects.
• Ability to communicate effectively with internal and external opinion leaders including pharmaceutical regulatory agencies.

#J-18808-Ljbffr

---